What is the best medication for managing agitation in older adults who want to go home?

Management of Agitation in Older Adults Who Want to Go Home

Direct Recommendation

Start immediately with non-pharmacological interventions to address the patient's desire to go home, and if medications become necessary due to dangerous agitation after behavioral approaches fail, use an SSRI (citalopram 10 mg/day or sertraline 25-50 mg/day) as first-line pharmacological treatment for chronic agitation, reserving low-dose risperidone (0.25-0.5 mg) or haloperidol (0.5-1 mg) only for severe acute agitation with imminent risk of harm. 1, 2

---

Step 1: Rule Out and Treat Reversible Causes First

Before any medication consideration, systematically investigate underlying medical triggers that commonly drive agitation in older adults who cannot effectively communicate distress:

• Pain is a major contributor to behavioral disturbances in patients who cannot verbally express discomfort 1, 2
• Infections, particularly urinary tract infections and pneumonia, must be ruled out 1
• Metabolic disturbances including hypoxia, dehydration, constipation, and urinary retention 1, 2
• Medication toxicity, especially anticholinergic medications that paradoxically worsen agitation 1, 2
• Sensory impairments such as hearing or vision deficits that increase confusion and fear 1

---

Step 2: Non-Pharmacological Interventions (Mandatory First-Line)

Environmental and behavioral modifications must be attempted and documented as failed before initiating any medication, as they have substantial evidence for efficacy without the mortality risks associated with pharmacological approaches 1, 2:

• Use calm tones, simple one-step commands, and gentle touch for reassurance rather than complex instructions 1
• Ensure adequate lighting and effective communication to maintain orientation 1, 2
• Establish consistent routines and simplify tasks to reduce confusion 2
• Time care activities when the patient is most calm and receptive 1
• Question whether the patient must leave their current location and consider whether care can be provided where they are comfortable 1
• Allow adequate time for the patient to process information before expecting a response 1

---

Step 3: Pharmacological Treatment Algorithm

For Chronic Mild-to-Moderate Agitation

SSRIs are the preferred first-line pharmacological option when non-pharmacological interventions have been thoroughly attempted for 24-48 hours without success 1, 2:

• Citalopram: Start 10 mg/day, maximum 40 mg/day 1, 2
• Sertraline: Start 25-50 mg/day, maximum 200 mg/day 1, 2

Evaluate response within 4 weeks of initiating treatment using quantitative measures (Cohen-Mansfield Agitation Inventory or NPI-Q), and if no clinically significant response after 4 weeks at adequate dose, taper and withdraw the medication 1, 2

For Severe Acute Agitation with Imminent Risk of Harm

Antipsychotics should only be used when the patient is severely agitated, threatening substantial harm to self or others, and behavioral interventions have failed or are not possible 1, 2:

First-line options for acute severe agitation:

• Risperidone: 0.25-0.5 mg at bedtime, maximum 2 mg/day (extrapyramidal symptoms increase above 2 mg/day) 1, 3, 4
• Haloperidol: 0.5-1 mg orally or subcutaneously, maximum 5 mg daily in elderly patients 1

Second-line option:

• Quetiapine: 12.5-25 mg twice daily initially, titrate slowly (more sedating with orthostatic hypotension risk) 1, 5, 3

Important note: Patients over 75 years respond less well to antipsychotics, particularly olanzapine 1

---

Critical Safety Warnings

Mortality Risk Discussion Required

Before initiating any antipsychotic, you must discuss with the patient (if feasible) and surrogate decision maker:

• Increased mortality risk (1.6-1.7 times higher than placebo) in elderly patients with dementia 1, 2
• Cardiovascular effects including QT prolongation, dysrhythmias, sudden death, and hypotension 1
• Falls risk, pneumonia, and metabolic changes 1, 2
• Expected benefits and treatment goals 1

Duration and Monitoring

• Use the lowest effective dose for the shortest possible duration 1, 2
• Evaluate ongoing need daily with in-person examination when using antipsychotics 1, 2
• Review the need at every visit and taper if no longer indicated 1
• Monitor for extrapyramidal symptoms, falls, metabolic changes, and cognitive worsening 1, 4

---

What NOT to Use

Avoid Benzodiazepines as First-Line

Benzodiazepines should not be first-line treatment for agitated delirium (except in alcohol or benzodiazepine withdrawal) because they:

• Increase delirium incidence and duration 1
• Cause paradoxical agitation in approximately 10% of elderly patients 1
• Lead to tolerance, addiction, cognitive impairment, and depression 1

Avoid Typical Antipsychotics as First-Line

Typical antipsychotics (haloperidol, fluphenazine, thiothixene) should be avoided as first-line therapy due to 50% risk of tardive dyskinesia after 2 years of continuous use in elderly patients 1, though low-dose haloperidol remains an option for acute severe agitation when immediate intervention is needed 1

Avoid Anticholinergic Medications

Anticholinergic medications worsen agitation in dementia and should be systematically reviewed and discontinued if possible 1, 2

---

Common Pitfalls to Avoid

• Do not continue antipsychotics indefinitely without regular reassessment—approximately 47% of patients continue receiving antipsychotics after discharge without clear indication 1
• Do not use antipsychotics for mild agitation—reserve them for severe symptoms that are dangerous or cause significant distress 1
• Do not skip non-pharmacological interventions unless in an emergency situation with imminent risk of harm 1, 2
• Do not use doses higher than recommended—the modal optimal risperidone dose in elderly patients with dementia is 0.5 mg/day 4